Books > Medicine > Other branches of medicine > Pharmacology
|
Buy Now
Leukotrienes - New Concepts and Targets for Therapy (Hardcover, 1998 ed.)
Loot Price: R4,289
Discovery Miles 42 890
|
|
Leukotrienes - New Concepts and Targets for Therapy (Hardcover, 1998 ed.)
Expected to ship within 12 - 17 working days
|
In the two decades since the elusive "slow reacting substance of
anaphylaxis" (SRS-A) was identified as a product of the action of
the 5-lipoxygenase enzyme on arachidonic acid, it has been well
established that the leukotrienes are key mediators of both alIergy
and inflammation. Their release by alIergen or other challenge has
been demonstrated in the lungs of asthmatic subjects, and
measurement of urinary leukotriene concentrations in such patients
has been shown to be a valuable, non invasive indicator.
Significant progress has been made towards the characterization of
the leukotriene receptor subtypes, exemplified by the cloning of
the LTB4 receptor earlier this year. Coupled with this there has
been a continued elucidation of signal transduction mechanisms
underlying receptor activation. Consequent upon these advances has
been the development of potent antagonists of the CysLT receptor, J
and both these and inhibitors of leukotriene biosynthesis have
entered clinical practice in the therapy of asthma. In this
clinical setting antagonists of the CysLTJ receptor have been shown
to be an effective therapy in chronic asthmatics, against antigen-
and exercise-induced bronchoconstriction, and in aspirin-intolerant
asthmatics. The advent of this new class of agents promises to
change the way in which asthmatic patients are currently treated."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.